search
Back to results

CCTG 593: Testing and Linkage to Care

Primary Purpose

HIV Positive, HIV Seronegative

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Linkage to PrEP or Care
Sponsored by
University of California, San Diego
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV Positive focused on measuring HIV Screening, Linkage to PrEP, Linkage to Care, CCTG, 593

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18 years or older
  • Has had an HIV test result form the CCTG Consortium testing site as either positive or negative
  • Ability to provide informed consent
  • English or Spanish Speaking

Exclusion Criteria:

  • Severe active substance abuse or mental illness that the investigator feels will interfere with the ability to provide informed consent
  • Acute medical illness that requires transfer to a non CCTG hospital

Sites / Locations

  • City of Long Beach Department of Health and Human Services
  • University of Southern California
  • University of California, San Diego

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Linkage to PrEP or Care

Arm Description

Subjects screened for HIV at any CCTG consortium site will be offered Linkage to PrEP or Care, depending on HIV status. After results are received, HIV testers will obtain verbal consent from the subject to connect with the ALERT Specialist, or otherwise offer the subject the ALERT Specialist contact information. When contacted, the ALERT Specialist will coordinate with the subject the scheduling of the PrEP or Care visit, and remain in contact to ensure linkage.

Outcomes

Primary Outcome Measures

Proportion of subjects linked to Care or PrEP
The primary outcome will measure the proportion of subjects linked a) to HIV care within 60 days of testing HIV-positive or b) to PrEP within 90 days of testing HIV-negative

Secondary Outcome Measures

Acceptance of the linkage program
Secondary outcomes will measure the acceptance of the linkage program, which is defined as those individuals who, after testing either positive or HIV antibody negative, will agree to be contacted by the ALERT specialist.

Full Information

First Posted
September 9, 2013
Last Updated
May 10, 2021
Sponsor
University of California, San Diego
Collaborators
University of California, Los Angeles, University of Southern California, City of Long Beach Department of Health and Human Services, California HIV/AIDS Research Program
search

1. Study Identification

Unique Protocol Identification Number
NCT01941121
Brief Title
CCTG 593: Testing and Linkage to Care
Official Title
CCTG 593: Testing and Linkage to Care, A Multicenter Demonstration Project of the California Collaborative Treatment Group
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
July 26, 2013 (Actual)
Primary Completion Date
January 22, 2018 (Actual)
Study Completion Date
February 9, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Diego
Collaborators
University of California, Los Angeles, University of Southern California, City of Long Beach Department of Health and Human Services, California HIV/AIDS Research Program

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a CCTG sponsored project to determine if those recently screened for HIV would accept assistance to be linked into appropriate health services. After receiving their HIV results, high-risk individuals who test negative will have an option to be linked into a study that offers them Pre-exposure Prophylaxis (PrEP), and individuals who test positive will have an option to be linked into care. If they accept, tested individuals will be in contact with an ALERT specialist that will help facilitate their linkage. The study's primary analysis will analyze how many HIV screened individuals accept the ALERT specialist assistance.
Detailed Description
Design: CCTG 593 is a project to evaluate the uptake and effectiveness of an ALERT specialist serving to link newly diagnosed, HIV infected persons from HIV testing sites to HIV specialist providers, and link confirmed HIV antibody negative persons with continued high risk behaviors to PrEP centers Duration: Each subject who agrees to linkage will receive ALERT follow-up until successful linkage or 60 days following enrollment for linkage to care or 90 days following enrollment for linkage to PrEP, whichever comes first. The duration of the 593 project will be for 3.5 years or until all subjects have been enrolled and successfully linked, or 60 days pass for linkage to care or 90 days for linkage to PrEP. Sample Size: Up to 600 subjects will be tested and offered linkage across all CCTG sites: LA County-USC Medical Center, Harbor-UCLA/City of Long Beach Department of Health and Human Services, UCSD/San Diego Health and Human Services Agency. Study Population: Eligible subjects will include any persons 18 years of age or older who have been tested for HIV at one of the CCTG testing sites (LA County + USC, Long Beach Department of Health and Human Services, and San Diego Health and Human Services Agency).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Positive, HIV Seronegative
Keywords
HIV Screening, Linkage to PrEP, Linkage to Care, CCTG, 593

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Linkage to PrEP or Care
Arm Type
Experimental
Arm Description
Subjects screened for HIV at any CCTG consortium site will be offered Linkage to PrEP or Care, depending on HIV status. After results are received, HIV testers will obtain verbal consent from the subject to connect with the ALERT Specialist, or otherwise offer the subject the ALERT Specialist contact information. When contacted, the ALERT Specialist will coordinate with the subject the scheduling of the PrEP or Care visit, and remain in contact to ensure linkage.
Intervention Type
Behavioral
Intervention Name(s)
Linkage to PrEP or Care
Intervention Description
Ensuring subjects complete linkage to PrEP or Care through coordinated scheduling and intensive reminders by ALERT Specialist.
Primary Outcome Measure Information:
Title
Proportion of subjects linked to Care or PrEP
Description
The primary outcome will measure the proportion of subjects linked a) to HIV care within 60 days of testing HIV-positive or b) to PrEP within 90 days of testing HIV-negative
Time Frame
Up to 60 days for positives and up to 90 days for negatives from date of HIV screening test
Secondary Outcome Measure Information:
Title
Acceptance of the linkage program
Description
Secondary outcomes will measure the acceptance of the linkage program, which is defined as those individuals who, after testing either positive or HIV antibody negative, will agree to be contacted by the ALERT specialist.
Time Frame
60 days from date of HIV screening test

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18 years or older Has had an HIV test result form the CCTG Consortium testing site as either positive or negative Ability to provide informed consent English or Spanish Speaking Exclusion Criteria: Severe active substance abuse or mental illness that the investigator feels will interfere with the ability to provide informed consent Acute medical illness that requires transfer to a non CCTG hospital
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Jacobson, MD
Organizational Affiliation
University of Southern California
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Michael Menchine, MD, MPH
Organizational Affiliation
University of Southern California
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Jill Blumenthal, MD
Organizational Affiliation
UC San Diego AntiViral Research Center (AVRC)
Official's Role
Principal Investigator
Facility Information:
Facility Name
City of Long Beach Department of Health and Human Services
City
Long Beach
State/Province
California
ZIP/Postal Code
90815
Country
United States
Facility Name
University of Southern California
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Facility Name
University of California, San Diego
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States

12. IPD Sharing Statement

Learn more about this trial

CCTG 593: Testing and Linkage to Care

We'll reach out to this number within 24 hrs